Annual report pursuant to Section 13 and 15(d)

Document Entity Information

Document Entity Information - USD ($)
12 Months Ended
Jun. 30, 2021
Sep. 15, 2021
Dec. 31, 2020
Cover [Abstract]      
Entity Registrant Name Anebulo Pharmaceuticals, Inc.    
Entity Central Index Key 0001815974    
Document Type 10-K    
Document Period End Date Jun. 30, 2021    
Amendment Flag false    
Current Fiscal Year End Date --06-30    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business Flag true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 16,382,340
Entity Common Stock, Shares Outstanding   23,344,567  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2021